Literature DB >> 18392083

Suppression of telomerase activity by pyrimethamine: implication to cancer.

Mohammad Reza Khorramizadeh1, Farshid Saadat1, Farhad Vaezzadeh1, Farnaz Safavifar1, Hassan Bashiri1, Zahra Jahanshiri1, Majid Momeny1, Abbas Mirshafiey1.   

Abstract

BACKGROUND: Although pyrimethamine (Tindurin) appears to be effective in the prevention and treatment of some infectious diseases, very little information exists on its unpredictable properties. We design this study to evaluate its anti-tumoral effect on a model of cell line.
METHODS: The cytotoxic influence of Pyrimethamine on prostate cell line was investigated using an in vitro colometric assay. The potential modulatory effects on metastasis, apoptosis, and immortality characteristics of cells were assessed with gelatin zymography, terminal deoxyribonucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay and telomeric repeat amplification protocol, respectively.
RESULTS: Cytotoxicity analysis of pyrimethamine revealed a dose-dependent fashion. An apoptotic influence of pyrimethamine was also confirmed by data obtained from TUNEL assay. Dose-dependent inhibitory effect on matrix metalloproteinases (MMP) was seen in pyrimethamine. A potent inhibitory effect of pyrimethamine was also established by data achieved from TRAPeze telomerase detection kit.
CONCLUSIONS: Collectively, as induction of apoptosis together with MMP and telomerase inhibition could be indicative of cancer treatment, pyrimethamine might be considered as a chemopreventative agent in cancer.

Entities:  

Keywords:  Telomerase; Cancer; Matrix metalloproteinases; Pyrimethamine

Mesh:

Substances:

Year:  2007        PMID: 18392083

Source DB:  PubMed          Journal:  Iran Biomed J        ISSN: 1028-852X


  4 in total

1.  The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer.

Authors:  Mohammad W Khan; Abdulrahman Saadalla; Ahmed H Ewida; Khalid Al-Katranji; Ghadier Al-Saoudi; Zachary T Giaccone; Fotini Gounari; Ming Zhang; David A Frank; Khashayarsha Khazaie
Journal:  Cancer Immunol Immunother       Date:  2017-09-05       Impact factor: 6.968

2.  Cutaneous plasmablastic lymphoma in an immunocompetent patient with long-term pyrimethamine use for essential thrombocythemia: a case report and literature review.

Authors:  Ing Soo Tiong; Magreet Strauss; Michael B Y Lau; Shingirai Chiruka
Journal:  Case Rep Hematol       Date:  2013-02-06

Review 3.  Therapeutic Targeting of Telomerase.

Authors:  Kathrin Jäger; Michael Walter
Journal:  Genes (Basel)       Date:  2016-07-21       Impact factor: 4.096

4.  Hepatocellular carcinoma-targeted drug discovery through image-based phenotypic screening in co-cultures of HCC cells with hepatocytes.

Authors:  Jae-Woo Jang; Yeonhwa Song; Kang Mo Kim; Jin-Sun Kim; Eun Kyung Choi; Joon Kim; Haengran Seo
Journal:  BMC Cancer       Date:  2016-10-18       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.